» Articles » PMID: 30246713

Feasibility Analysis of Oxygen-Glucose Deprivation-Nutrition Resumption on H9c2 Cells Models of Myocardial Ischemia-Reperfusion Injury

Overview
Specialty General Medicine
Date 2018 Sep 25
PMID 30246713
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Oxygen-glucose deprivation-nutrition resumption (OGD-NR) models on H9c2 cells are commonly used in vitro models of simulated myocardial ischemia-reperfusion injury (MIRI), but no study has assessed whether these methods for establishing in vitro models can effectively imitate the characteristics of MIRI in vivo. This experiment was designed to analyze the feasibility of six OGD-NR models of MIRI.

Methods: By searching the PubMed database using the keywords "myocardial reperfusion injury H9c2 cells," we obtained six commonly used OGD-NR in vitro models of MIRI performed on H9c2 cells from more than 400 published papers before January 30, 2017. For each model, control (C), simulated ischemia (SI), and simulated ischemia-reperfusion (SIR) groups were assigned, and cell morphology, lactate dehydrogenase (LDH) release, adenosine triphosphate (ATP) levels, reactive oxygen species (ROS), mitochondrial membrane potential (MMP), and inflammatory cytokines were examined to evaluate the characteristics of cell injury. Subsequently, a coculture system of cardiomyocyte-endothelial-macrophage was constructed. The coculture system was dealt with SI and SIR treatments to test the effect on cardiomyocytes survival.

Results: For models 1, 2, 3, 4, 5, and 6, SI treatment caused morphological damage to cells, and subsequent SIR treatment did not cause further morphological damage. In the models 1, 2, 3, 4, 5 and 6, LDH release was significantly higher in the SI groups than that in the C group (P < 0.05), and was significantly lower in the SIR groups than that in the SI groups (P < 0.05), except for no significant differences in the LDH release between C, SI and SIR groups in model 6 receiving a 3-h SI treatment. In models 1, 2, 3, 4, 5, and 6, compared with the C group, ATP levels of the SI groups significantly decreased (P < 0.05), ROS levels increased (P < 0.05), and MMP levels decreased (P < 0.05). Compared with the SI group, ATP level of the SIR groups was significantly increased (P < 0.05), and there was no significant ROS production, MMP collapse, and over inflammatory response in the SIR groups. In a coculture system of H9c2 cells-endothelial cells-macrophages, the proportion of viable H9c2 cells in the SIR groups was not reduced compared with the SI groups.

Conclusion: All the six OGD-NR models on H9c2 cells in this experiment can not imitate the characteristics of MIRI in vivo and are not suitable for MIRI-related study.

Citing Articles

GCN5L1-mediated acetylation prevents Rictor degradation in cardiac cells after hypoxic stress.

Bugga P, Manning J, Mushala B, Stoner M, Sembrat J, Scott I Cell Signal. 2024; 116:111065.

PMID: 38281616 PMC: 10922666. DOI: 10.1016/j.cellsig.2024.111065.


GCN5L1-mediated acetylation prevents Rictor degradation in cardiac cells after hypoxic stress.

Bugga P, Manning J, Mushala B, Stoner M, Sembrat J, Scott I bioRxiv. 2023; .

PMID: 37961692 PMC: 10634848. DOI: 10.1101/2023.10.26.564170.


The protective effects of GLP-1 receptor agonist lixisenatide on oxygen-glucose deprivation/reperfusion (OGD/R)-induced deregulation of endothelial tube formation.

Xiao M, Lu D, Tian J, Yu Y, Zhang Q, Zhang L RSC Adv. 2022; 10(17):10245-10253.

PMID: 35498599 PMC: 9050383. DOI: 10.1039/c9ra09959j.


The optimal model of reperfusion injury using H9c2 transformed cardiac myoblasts.

Son E, Lee D, Woo C, Kim Y Korean J Physiol Pharmacol. 2020; 24(2):173-183.

PMID: 32140041 PMC: 7043999. DOI: 10.4196/kjpp.2020.24.2.173.

References
1.
Almohammedi A, Kapetanaki S, Wood B, Raven E, Storey N, Hudson A . Spectroscopic analysis of myoglobin and cytochrome c dynamics in isolated cardiomyocytes during hypoxia and reoxygenation. J R Soc Interface. 2015; 12(105). PMC: 4387523. DOI: 10.1098/rsif.2014.1339. View

2.
Pasque M, Wechsler A . Metabolic intervention to affect myocardial recovery following ischemia. Ann Surg. 1984; 200(1):1-12. PMC: 1250384. DOI: 10.1097/00000658-198407000-00001. View

3.
Siegmund B, Klietz T, Schwartz P, Piper H . Temporary contractile blockade prevents hypercontracture in anoxic-reoxygenated cardiomyocytes. Am J Physiol. 1991; 260(2 Pt 2):H426-35. DOI: 10.1152/ajpheart.1991.260.2.H426. View

4.
Hearse D, Humphrey S, CHAIN E . Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol. 1973; 5(4):395-407. DOI: 10.1016/0022-2828(73)90030-8. View

5.
Boccalini G, Sassoli C, Formigli L, Bani D, Nistri S . Relaxin protects cardiac muscle cells from hypoxia/reoxygenation injury: involvement of the Notch-1 pathway. FASEB J. 2014; 29(1):239-49. DOI: 10.1096/fj.14-254854. View